of the SSc process via oestrogen receptor interactions. 4 The role of hormones in disease manifestation is also evident when considering SSc-associated pulmonary arterial hypertension. 5 Moreover, autoantibodies to oestrogen receptors have been found to correlate with disease activity in scleroderma patients. 6 Although pulmonary arterial hypertension occurs more frequently in females, males with this complication show an increased frequency of other serious SSc disease manifestations, such as scleroderma renal crisis, diffuse cutaneous disease, interstitial lung disease and an increased risk of mortality. 5 Genetic and environmental factors have been suggested to be involved in the aetiology of this disease, but the exact mechanisms involved in SSc pathogenesis are not well understood.
Several years ago Murrel 7 linked, for the first time, the pathogenesis of SSc to the occurring of oxidative stress. Several reports 8, 9 have supported this hypothesis for both lc-SSc and dc-SSc, although Oxidative post-transcriptional protein modifications, for example, nitrated proteins, known to be a marker of
• NO-derived oxidants, 29 and advanced oxidation protein products (AOPP) have been measured in SSc plasma and skin. 30 Interestingly, AOPP in turn seems to be able to stimulate ROS formation in cell targets. Indeed, serum containing high AOPP levels isolated from SSc patients has been found to stimulate endothelial cells and fibroblasts from healthy donors to generate ROS involved in vascular or fibrotic complications. 30 Interestingly, AOPP generated by different oxidation patterns can induce the selective triggering of cells to produce H 2 O 2 or
• NO, suggesting that these oxidation products may be involved in the generation of different types of ROS in SSc patients. 30 Moreover, urinary levels of both 8-hydroxy-2 0 deoxyguanosine (the main validated biomarker of endogenous oxidative damage to DNA) and F2-isoprostane (a product of ROS-mediated arachidonic acid peroxidation) were found to be higher in SSc patients than in controls. 31 VONA ET AL.
| 3309
The multivariate analysis indicated a relevant association with a fibrotic phenotype. In fact, 8-hydroxy-2 0 deoxyguanosine levels were significantly associated with the presence of pulmonary fibrosis, decreased forced vital capacity and decreased alveolar volume suggesting a potential predictive value of this biomarker. 31 Biomarkers of oxidative stress detected in SSc are listed in Table 1 .
| PLASMA ANTIOXIDANT CAPACITY IN SSC
The total antioxidant capacity (TAC), which accounts for the ability of tissues to counteract oxidative stress, has been reported to be decreased in plasma of SSc patients. 14 (Figure 1) . 38 Cells involved in ROS production are reported below. 
| Monocytes

| Red blood cells
Because of their high iron concentration (~20 mmol/L), red blood cells (RBCs) can be considered as an "iron mine" but, paradoxically, they also represent one of the major components of blood antioxidant capacity and one of the cells with higher resistance to oxidative F I G U R E 1 Sources of reactive oxidizing species (ROS) in SSc. In SSc, ROS may be generated inside the vascular lumen by activated monocytes and macrophages, erythrocytes, endothelial cells and fibroblasts. In addition to ROS, activated endothelial cells release adhesion molecules, which can trigger an inflammatory cascade, elevating the plasma levels of pro-inflammatory cytokines in patients stress. 48 Crossing Bax is a pro-apoptotic member of the Bcl-2 family. 51 Moreover, it has been demonstrated that both cellular Abelson (c-Abl) and TGFb1 serve as apoptosis suppressors in human dermal fibroblasts. c-Abl is known as a TGF-b1-modulating molecule in fibrosis. TGF-b1 is an important cytokine that induces fibroblast differentiation into myofibroblasts and is considered to be the major factor towards chronic fibrosis. SSc patients express elevated TGF-b1 levels in the early lesions, but not in established fibrotic tissue. 52 Kim and collaborators demonstrated that TGF-b1 induced the activation of Akt in normal and RA synovial fibroblasts, and that TGF-b1 exerted its anti-apoptotic effect, in part, through the PI3 kinase/Akt pathway. progression cannot be ruled out.
